We applied genome sequencing approaches, in vitro and in vivo methods to reveal the tumor suppressor role of ZNF750 and a possible novel mechanism underlying malignant phenotypes caused by loss-function of ZNF750 in ESCC. This evidence concerns the gene ZNF750 and neoplasm.